Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 75907-225

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 75907-225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

This is a description of a medication called Azacitidine for Injection. It is a cytotoxic agent that comes in a single-dose vial containing 100 mg of azacitidine and 100 mg of mannitol. The medication is intended for subcutaneous and intravenous use only and must be diluted before administration. The usual dosage and administration instructions can be found in the prescribing information. Unused portions should be discarded, and the medication should be kept out of reach of children. It should be stored at 20°C to 25°C and the expiration date can be found on the label.*

FDA Label Image

Vial (Vial)

FDA Label Image

Graph (Graph)

This text provides statistical data on a comparison between two groups using log-rank analysis. The p-value is 0.00001, indicating a significant difference between the groups. The Hazard Ratio (HR) is 0.58 with a 95% confidence interval of 0.43 to 0.77. There were 82 deaths in the AZA group and 113 deaths in the CCR group. The data also includes information on the proportion surviving over time for each group, showing the number at risk at various time points in months.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.